Oracle's Cloud Growth and Preferred Stock Opportunity
Finance

Oracle's Cloud Growth and Preferred Stock Opportunity

authorBy Nouriel Roubini
DateJul 21, 2026
Read time2 min

Oracle Corporation (ORCL) is currently experiencing substantial growth in its cloud services, underscored by a remarkable $638 billion in remaining performance obligations. This robust demand highlights the company's strong position in the expanding cloud computing market. However, the critical consideration for investors extends beyond just this growth, encompassing the implications of Oracle's financial structure, particularly its significant debt and lease commitments.

For investors considering Oracle, a compelling opportunity lies in its preferred shares, specifically ORCL.PR.D. These preferred shares offer an appealing nearly 8% yield and include conversion terms that could provide superior risk-adjusted returns. In market conditions that are either stable or show moderate bullish trends, the preferred shares are positioned to outperform common shares, especially since they offer both income generation and a degree of downside protection. This would generally hold true unless Oracle's common stock price appreciates by more than 42% to exceed $179 by January 2029.

Despite the attractive aspects of the preferred shares, several significant risks warrant attention. These include Oracle's negative free cash flow, increasing leverage, and a concentration of customers that could impact revenue stability. Furthermore, it's crucial to acknowledge that the preferred shares are subordinate to all of Oracle's existing debt. These factors collectively require investors to conduct a thorough evaluation of the company's financial health and market position before making investment decisions.

Investing wisely involves a careful balance of potential gains and inherent risks. While Oracle's preferred shares present an attractive income opportunity with defensive characteristics, understanding the underlying financial pressures and market dynamics is paramount. It is in navigating these complexities that investors can find clarity and make informed choices to align with their financial aspirations.

More Articles
Finance
NVIDIA's Strategic Shift: Investing in Future AI Beyond Core GPUs
NVIDIA is navigating increasing competition from affordable Chinese alternatives and custom silicon from hyperscalers. To counter these pressures and maintain its leadership, CEO Jensen Huang is spearheading a strategy focused on investing in nascent "zero-billion-dollar markets" such as quantum computing, physical AI, and digital biology. This forward-looking approach leverages NVIDIA's software platforms and involves direct investments, aiming to define future industry opportunities rather than solely relying on its GPU-centric core.
By Michele FerreroJul 21, 2026
Finance
Donnelley Financial Solutions: Software Transition Fuels Growth and Investor Confidence
Donnelley Financial Solutions (DFIN) is actively transforming its business model by prioritizing compliance-focused software solutions for regulatory filings, capital markets, and financial reporting. This strategic shift is reflected in its increasing software-derived net sales, which currently account for 44.6% of total revenue, with an ambitious long-term goal of reaching 60%. The company's platforms, ActiveDisclosure and Arcflex, are pivotal to this growth, driven by escalating regulatory demands and a rising tide of recurring subscription revenues. Additionally, DFIN is poised for robust Q2 2026 earnings, benefiting from a thriving IPO and M&A landscape. With its stock trading at a historically low forward EV/EBITDA multiple of 6x and a consistent track record of surpassing EPS forecasts, DFIN presents a compelling investment opportunity.
By Lisa JingJul 21, 2026
Finance
BNY Mellon Core Plus Fund's Q2 2026 Performance and Market Review
BNY Mellon Core Plus Fund's Class I shares achieved a 1.39% return in Q2 2026, outperforming the Bloomberg U.S. Aggregate Bond Index. This success was primarily driven by strategic allocations to high yield corporate bonds, convertible securities, and emerging market debt. The quarter also saw significant shifts in inflation metrics, with both headline and core CPI and PCE rising notably. The Federal Open Market Committee adopted a more hawkish stance, impacting market dynamics.
By Michele FerreroJul 21, 2026
Finance
Understanding Duopolies: Dynamics, Advantages, and Disadvantages
A duopoly is a market structure dominated by two firms. This article explores the nature of duopolies, distinguishing them from monopolies and oligopolies, and examines their economic implications, including potential benefits like controlled pricing through competition, and drawbacks such as limited consumer choice and the risk of collusion. Key examples and types of duopolies are also discussed.
By Strive MasiyiwaJul 21, 2026
Finance
Karyopharm Therapeutics Faces Headwinds: Downgraded to 'Hold' Amid Sales Struggles and Regulatory Challenges
Karyopharm Therapeutics (KPTI) has been downgraded to 'Hold' from 'Strong Buy' due to disappointing XPOVIO sales and regulatory hurdles. The company projects 2026 U.S. XPOVIO sales between $115–$130 million, facing increasing competition in multiple myeloma. The FDA rejected the sNDA for selinexor in endometrial cancer, though a new Phase 3 trial is underway. Mixed results from the Phase 3 SENTRY trial for myelofibrosis also add to the uncertainty.
By Michele FerreroJul 21, 2026